Rank | Gene Set | Z-score |
---|---|---|
1 | microglial cell activation (GO:0001774) | 9.75212289 |
2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 7.80136031 |
3 | modulation by symbiont of host immune response (GO:0052553) | 7.73170878 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 7.73170878 |
5 | modulation by symbiont of host defense response (GO:0052031) | 7.73170878 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.73170878 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.73170878 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.73170878 |
9 | macrophage activation involved in immune response (GO:0002281) | 7.41230846 |
10 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 6.22215341 |
11 | negative regulation of granulocyte differentiation (GO:0030853) | 6.12179527 |
12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.11217071 |
13 | macrophage activation (GO:0042116) | 5.68601653 |
14 | keratan sulfate catabolic process (GO:0042340) | 5.14224866 |
15 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 5.07080061 |
16 | positive regulation of interferon-alpha production (GO:0032727) | 4.99798585 |
17 | response to host immune response (GO:0052572) | 4.71511120 |
18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.71511120 |
19 | regulation of interferon-alpha production (GO:0032647) | 4.68435045 |
20 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.66502709 |
21 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.60401769 |
22 | response to host (GO:0075136) | 4.60401769 |
23 | response to host defenses (GO:0052200) | 4.60401769 |
24 | I-kappaB phosphorylation (GO:0007252) | 4.51570919 |
25 | glycosphingolipid catabolic process (GO:0046479) | 4.50097232 |
26 | oligosaccharide catabolic process (GO:0009313) | 4.48011283 |
27 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 4.40992458 |
28 | mannose metabolic process (GO:0006013) | 4.38250292 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.35743164 |
30 | hyaluronan catabolic process (GO:0030214) | 4.28955790 |
31 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 4.27439108 |
32 | positive regulation of B cell differentiation (GO:0045579) | 4.15378088 |
33 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 4.10954711 |
34 | positive regulation of mast cell degranulation (GO:0043306) | 4.10954711 |
35 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 4.09725126 |
36 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 4.09112166 |
37 | positive regulation of mast cell activation (GO:0033005) | 4.06979097 |
38 | detection of molecule of bacterial origin (GO:0032490) | 4.03899909 |
39 | glycolipid catabolic process (GO:0019377) | 4.01664621 |
40 | myeloid cell activation involved in immune response (GO:0002275) | 3.97681931 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.97303172 |
42 | chondroitin sulfate catabolic process (GO:0030207) | 3.95203899 |
43 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.94243361 |
44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92519230 |
45 | negative regulation of cell killing (GO:0031342) | 3.92519230 |
46 | detection of other organism (GO:0098543) | 3.86062492 |
47 | negative regulation of interleukin-6 production (GO:0032715) | 3.76121795 |
48 | cellular extravasation (GO:0045123) | 3.69858490 |
49 | pathway-restricted SMAD protein phosphorylation (GO:0060389) | 3.69667925 |
50 | regulation of leukocyte degranulation (GO:0043300) | 3.68549591 |
51 | detection of external biotic stimulus (GO:0098581) | 3.65641981 |
52 | germ cell migration (GO:0008354) | 3.61683466 |
53 | regulation of mononuclear cell migration (GO:0071675) | 3.57515543 |
54 | purinergic receptor signaling pathway (GO:0035587) | 3.56998842 |
55 | ceramide catabolic process (GO:0046514) | 3.56435532 |
56 | detection of bacterium (GO:0016045) | 3.55722699 |
57 | positive regulation of leukocyte degranulation (GO:0043302) | 3.55583478 |
58 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.52757715 |
59 | negative regulation of bone resorption (GO:0045779) | 3.52076809 |
60 | immunoglobulin mediated immune response (GO:0016064) | 3.51990382 |
61 | regulation of gamma-delta T cell activation (GO:0046643) | 3.51569904 |
62 | regulation of mast cell activation (GO:0033003) | 3.50552921 |
63 | response to muramyl dipeptide (GO:0032495) | 3.49183110 |
64 | T-helper 1 type immune response (GO:0042088) | 3.42828734 |
65 | regulation of hypersensitivity (GO:0002883) | 3.42683375 |
66 | respiratory burst (GO:0045730) | 3.38957195 |
67 | regulation of monocyte differentiation (GO:0045655) | 3.38855189 |
68 | negative regulation of tissue remodeling (GO:0034104) | 3.37910192 |
69 | response to cholesterol (GO:0070723) | 3.37451289 |
70 | amino sugar catabolic process (GO:0046348) | 3.36534277 |
71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.35182191 |
72 | B cell mediated immunity (GO:0019724) | 3.33986430 |
73 | response to peptidoglycan (GO:0032494) | 3.33471479 |
74 | lysosome organization (GO:0007040) | 3.31892633 |
75 | lytic vacuole organization (GO:0080171) | 3.31892633 |
76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.27088966 |
77 | detection of biotic stimulus (GO:0009595) | 3.26734023 |
78 | positive regulation of interferon-beta production (GO:0032728) | 3.26298929 |
79 | neutrophil activation involved in immune response (GO:0002283) | 3.25110382 |
80 | neutrophil activation (GO:0042119) | 3.24801657 |
81 | regulation of antigen processing and presentation (GO:0002577) | 3.19352886 |
82 | apoptotic cell clearance (GO:0043277) | 3.19143322 |
83 | adaptation of signaling pathway (GO:0023058) | 3.17996354 |
84 | N-acetylneuraminate metabolic process (GO:0006054) | 3.17823462 |
85 | regulation of macrophage chemotaxis (GO:0010758) | 3.15017806 |
86 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.13723134 |
87 | germinal center formation (GO:0002467) | 3.12859933 |
88 | response to laminar fluid shear stress (GO:0034616) | 3.11502139 |
89 | tolerance induction (GO:0002507) | 3.09681530 |
90 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06697425 |
91 | adenosine receptor signaling pathway (GO:0001973) | 3.06051070 |
92 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.05406753 |
93 | myeloid leukocyte activation (GO:0002274) | 3.05026310 |
94 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.04803414 |
95 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04703451 |
96 | macrophage chemotaxis (GO:0048246) | 3.02897221 |
97 | sodium-independent organic anion transport (GO:0043252) | 3.00139113 |
98 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.98602706 |
99 | regulation of granulocyte differentiation (GO:0030852) | 2.98078066 |
100 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.97386051 |
101 | regulation of regulated secretory pathway (GO:1903305) | 2.94924225 |
102 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.90878179 |
103 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90766051 |
104 | receptor catabolic process (GO:0032801) | 2.87483965 |
105 | negative regulation of B cell proliferation (GO:0030889) | 2.87164986 |
106 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86268296 |
107 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84487061 |
108 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.84002160 |
109 | myeloid dendritic cell differentiation (GO:0043011) | 2.81380895 |
110 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.80569697 |
111 | response to sterol (GO:0036314) | 2.79862823 |
112 | phagocytosis, engulfment (GO:0006911) | 2.79839347 |
113 | myeloid dendritic cell activation (GO:0001773) | 2.79363917 |
114 | regulation of mast cell degranulation (GO:0043304) | 2.79301591 |
115 | regulation of T cell tolerance induction (GO:0002664) | 2.78967852 |
116 | negative regulation of bone remodeling (GO:0046851) | 2.76755902 |
117 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76341258 |
118 | regulation of B cell differentiation (GO:0045577) | 2.76062577 |
119 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.74947599 |
120 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.74300509 |
121 | NIK/NF-kappaB signaling (GO:0038061) | 2.72541856 |
122 | cortical actin cytoskeleton organization (GO:0030866) | 2.72226588 |
123 | pinocytosis (GO:0006907) | 2.71770119 |
124 | negative regulation of interleukin-17 production (GO:0032700) | 2.70826768 |
125 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.69805715 |
126 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.69448084 |
127 | defense response to protozoan (GO:0042832) | 2.69347518 |
128 | regulation of erythrocyte differentiation (GO:0045646) | 2.69055907 |
129 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.68500994 |
130 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.67888862 |
131 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67324729 |
132 | neutrophil migration (GO:1990266) | 2.66971822 |
133 | monocyte chemotaxis (GO:0002548) | 2.66772957 |
134 | negative regulation of macrophage differentiation (GO:0045650) | 2.65698676 |
135 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.65472465 |
136 | barbed-end actin filament capping (GO:0051016) | 2.65387814 |
137 | B cell receptor signaling pathway (GO:0050853) | 2.65161223 |
138 | response to thyroid hormone (GO:0097066) | 2.64847010 |
139 | regulation of tolerance induction (GO:0002643) | 2.64744777 |
140 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.64676084 |
141 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.64243726 |
142 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.63307791 |
143 | cyclooxygenase pathway (GO:0019371) | 2.57881669 |
144 | negative regulation of interleukin-12 production (GO:0032695) | 2.55849977 |
145 | dendritic cell differentiation (GO:0097028) | 2.54083256 |
146 | granulocyte activation (GO:0036230) | 2.53745298 |
147 | neutrophil chemotaxis (GO:0030593) | 2.53593194 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.52317513 |
2 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.79686844 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.67693211 |
4 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.27302601 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89360041 |
6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.87685653 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.38820146 |
8 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.34750909 |
9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.31662019 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.18383565 |
11 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.99473275 |
12 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.91906452 |
13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83935618 |
14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59422253 |
15 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.57185229 |
16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.53464758 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.37519024 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.36033984 |
19 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.31854291 |
20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.19442107 |
21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.14669362 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.09982377 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06417927 |
24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.04152986 |
25 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.02714666 |
26 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.92140462 |
27 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.90063034 |
28 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81756163 |
29 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.80673945 |
30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78000233 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.76073378 |
32 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.68985523 |
33 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64503664 |
34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.61969201 |
35 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.59810681 |
36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.59778707 |
37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59000683 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56942654 |
39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53775732 |
40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.50426075 |
41 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.45210951 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45106638 |
43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41923244 |
44 | MAF_26560356_Chip-Seq_TH1_Human | 1.41475991 |
45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39343619 |
46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.39124163 |
47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.37974755 |
48 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.37317923 |
49 | MYC_22102868_ChIP-Seq_BL_Human | 1.35961224 |
50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35292035 |
51 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.34234379 |
52 | GATA2_19941826_ChIP-Seq_K562_Human | 1.30187460 |
53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29920050 |
54 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28164606 |
55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26557481 |
56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25724739 |
57 | MYB_26560356_Chip-Seq_TH2_Human | 1.25510312 |
58 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23677624 |
59 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22756552 |
60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22463779 |
61 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.19607111 |
62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19301375 |
63 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.16634084 |
64 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16474108 |
65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.16134338 |
66 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12972897 |
67 | MYB_26560356_Chip-Seq_TH1_Human | 1.12397516 |
68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11347432 |
69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.11304985 |
70 | MAF_26560356_Chip-Seq_TH2_Human | 1.09032225 |
71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.08515786 |
72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.08183455 |
73 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07679414 |
74 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.07553758 |
75 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.07553758 |
76 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.07553758 |
77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07318970 |
78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06536387 |
79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04946618 |
80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.04222568 |
81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02144639 |
82 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.01898892 |
83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01527990 |
84 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01233154 |
85 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.00181543 |
86 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99742656 |
87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.99606250 |
88 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.98360175 |
89 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94878330 |
90 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94694112 |
91 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.93027875 |
92 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.91187933 |
93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90203890 |
94 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89799163 |
95 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89197993 |
96 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.87997100 |
97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87718640 |
98 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87653241 |
99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87448774 |
100 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87310753 |
101 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87292890 |
102 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.86406361 |
103 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86384842 |
104 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85473888 |
105 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85441483 |
106 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.84860324 |
107 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84121472 |
108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83755683 |
109 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83583842 |
110 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81822585 |
111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81775766 |
112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.81720708 |
113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.81681053 |
114 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80467993 |
115 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.80066640 |
116 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.79079283 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005058_abnormal_lysosome_morphology | 5.21104311 |
2 | MP0006082_CNS_inflammation | 5.07436417 |
3 | MP0003191_abnormal_cellular_cholesterol | 4.96083435 |
4 | MP0003172_abnormal_lysosome_physiology | 4.13203875 |
5 | MP0003303_peritoneal_inflammation | 3.66329876 |
6 | MP0001835_abnormal_antigen_presentation | 3.20750501 |
7 | MP0009840_abnormal_foam_cell | 3.08509031 |
8 | MP0003690_abnormal_glial_cell | 2.85123944 |
9 | MP0005671_abnormal_response_to | 2.84667333 |
10 | MP0005464_abnormal_platelet_physiology | 2.80472491 |
11 | MP0002419_abnormal_innate_immunity | 2.73050850 |
12 | MP0003075_altered_response_to | 2.50653083 |
13 | MP0003300_gastrointestinal_ulcer | 2.39478904 |
14 | MP0003436_decreased_susceptibility_to | 2.30247682 |
15 | MP0003183_abnormal_peptide_metabolism | 2.15703443 |
16 | MP0005000_abnormal_immune_tolerance | 2.06699372 |
17 | * MP0002452_abnormal_antigen_presenting | 2.05508797 |
18 | MP0003724_increased_susceptibility_to | 1.95802330 |
19 | MP0000343_altered_response_to | 1.92421880 |
20 | MP0008004_abnormal_stomach_pH | 1.85912572 |
21 | * MP0002723_abnormal_immune_serum | 1.85622326 |
22 | MP0001800_abnormal_humoral_immune | 1.85183721 |
23 | MP0001851_eye_inflammation | 1.84601685 |
24 | MP0002148_abnormal_hypersensitivity_rea | 1.84460951 |
25 | MP0009278_abnormal_bone_marrow | 1.83269243 |
26 | MP0009764_decreased_sensitivity_to | 1.76651339 |
27 | MP0005025_abnormal_response_to | 1.75538087 |
28 | MP0005167_abnormal_blood-brain_barrier | 1.73330339 |
29 | MP0002928_abnormal_bile_duct | 1.66024313 |
30 | MP0002420_abnormal_adaptive_immunity | 1.65582907 |
31 | * MP0001819_abnormal_immune_cell | 1.65156983 |
32 | MP0000465_gastrointestinal_hemorrhage | 1.63683674 |
33 | MP0005166_decreased_susceptibility_to | 1.60436115 |
34 | MP0003566_abnormal_cell_adhesion | 1.59157694 |
35 | MP0004185_abnormal_adipocyte_glucose | 1.58478124 |
36 | MP0004510_myositis | 1.56409342 |
37 | MP0005670_abnormal_white_adipose | 1.56329571 |
38 | MP0005387_immune_system_phenotype | 1.53807574 |
39 | MP0001790_abnormal_immune_system | 1.53807574 |
40 | * MP0001533_abnormal_skeleton_physiology | 1.49373875 |
41 | * MP0008469_abnormal_protein_level | 1.47071261 |
42 | MP0001845_abnormal_inflammatory_respons | 1.42715360 |
43 | MP0005451_abnormal_body_composition | 1.42556678 |
44 | MP0003252_abnormal_bile_duct | 1.42316101 |
45 | MP0002139_abnormal_hepatobiliary_system | 1.41078075 |
46 | MP0008260_abnormal_autophagy | 1.40050743 |
47 | MP0000858_altered_metastatic_potential | 1.36639562 |
48 | MP0002090_abnormal_vision | 1.35171015 |
49 | MP0001915_intracranial_hemorrhage | 1.34605457 |
50 | MP0000685_abnormal_immune_system | 1.33539589 |
51 | MP0003045_fibrosis | 1.28698795 |
52 | MP0002405_respiratory_system_inflammati | 1.28632175 |
53 | MP0009785_altered_susceptibility_to | 1.24969654 |
54 | MP0001545_abnormal_hematopoietic_system | 1.24469251 |
55 | MP0005397_hematopoietic_system_phenotyp | 1.24469251 |
56 | MP0004883_abnormal_blood_vessel | 1.24356915 |
57 | MP0000604_amyloidosis | 1.23917875 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.23424519 |
59 | * MP0000689_abnormal_spleen_morphology | 1.20511490 |
60 | MP0000569_abnormal_digit_pigmentation | 1.20249891 |
61 | * MP0000716_abnormal_immune_system | 1.18744379 |
62 | MP0003329_amyloid_beta_deposits | 1.18650048 |
63 | MP0000767_abnormal_smooth_muscle | 1.10871055 |
64 | MP0000249_abnormal_blood_vessel | 1.09608076 |
65 | MP0002396_abnormal_hematopoietic_system | 1.07340659 |
66 | MP0005310_abnormal_salivary_gland | 1.04810637 |
67 | MP0004947_skin_inflammation | 1.04796763 |
68 | MP0003828_pulmonary_edema | 1.04093202 |
69 | MP0002254_reproductive_system_inflammat | 1.03568389 |
70 | MP0005023_abnormal_wound_healing | 1.03438362 |
71 | MP0001853_heart_inflammation | 1.02322301 |
72 | MP0003279_aneurysm | 1.01749827 |
73 | * MP0002398_abnormal_bone_marrow | 1.01716063 |
74 | MP0002166_altered_tumor_susceptibility | 1.01572027 |
75 | MP0003806_abnormal_nucleotide_metabolis | 1.01409515 |
76 | MP0008873_increased_physiological_sensi | 1.01353366 |
77 | MP0008007_abnormal_cellular_replicative | 1.00739090 |
78 | * MP0002998_abnormal_bone_remodeling | 1.00336628 |
79 | MP0000920_abnormal_myelination | 1.00055494 |
80 | MP0005666_abnormal_adipose_tissue | 0.99691137 |
81 | * MP0002722_abnormal_immune_system | 0.95143736 |
82 | * MP0002429_abnormal_blood_cell | 0.94723218 |
83 | MP0004130_abnormal_muscle_cell | 0.94554585 |
84 | MP0003656_abnormal_erythrocyte_physiolo | 0.93880335 |
85 | MP0003633_abnormal_nervous_system | 0.92388926 |
86 | MP0010155_abnormal_intestine_physiology | 0.91749784 |
87 | MP0003195_calcinosis | 0.89469676 |
88 | MP0003448_altered_tumor_morphology | 0.87380852 |
89 | MP0003634_abnormal_glial_cell | 0.86484429 |
90 | MP0005165_increased_susceptibility_to | 0.84184649 |
91 | MP0006054_spinal_hemorrhage | 0.83508446 |
92 | MP0008438_abnormal_cutaneous_collagen | 0.82406645 |
93 | MP0003091_abnormal_cell_migration | 0.81577306 |
94 | * MP0005390_skeleton_phenotype | 0.79827226 |
95 | MP0008874_decreased_physiological_sensi | 0.78903285 |
96 | MP0005164_abnormal_response_to | 0.78680179 |
97 | MP0000609_abnormal_liver_physiology | 0.78658976 |
98 | MP0003453_abnormal_keratinocyte_physiol | 0.76938981 |
99 | * MP0003795_abnormal_bone_structure | 0.76859831 |
100 | MP0001663_abnormal_digestive_system | 0.76600556 |
101 | MP0003763_abnormal_thymus_physiology | 0.76461047 |
102 | MP0009763_increased_sensitivity_to | 0.75931660 |
103 | MP0003866_abnormal_defecation | 0.73763928 |
104 | MP0002138_abnormal_hepatobiliary_system | 0.71805104 |
105 | MP0005365_abnormal_bile_salt | 0.69778977 |
106 | MP0002277_abnormal_respiratory_mucosa | 0.68849134 |
107 | MP0003705_abnormal_hypodermis_morpholog | 0.66957023 |
108 | MP0004808_abnormal_hematopoietic_stem | 0.66160993 |
109 | MP0003638_abnormal_response/metabolism_ | 0.65679901 |
110 | MP0002933_joint_inflammation | 0.65014570 |
111 | MP0010307_abnormal_tumor_latency | 0.64001561 |
112 | MP0005085_abnormal_gallbladder_physiolo | 0.63977384 |
113 | MP0002006_tumorigenesis | 0.63358888 |
114 | MP0000598_abnormal_liver_morphology | 0.63161724 |
115 | MP0001873_stomach_inflammation | 0.62740412 |
116 | MP0002135_abnormal_kidney_morphology | 0.62659694 |
117 | MP0005197_abnormal_uvea_morphology | 0.62562810 |
118 | MP0009115_abnormal_fat_cell | 0.62200536 |
119 | MP0002136_abnormal_kidney_physiology | 0.61264351 |
120 | MP0002332_abnormal_exercise_endurance | 0.59136340 |
121 | MP0005595_abnormal_vascular_smooth | 0.58277511 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.57952621 |
123 | MP0000015_abnormal_ear_pigmentation | 0.57698579 |
124 | MP0001986_abnormal_taste_sensitivity | 0.56126304 |
125 | MP0003879_abnormal_hair_cell | 0.54334603 |
126 | MP0002971_abnormal_brown_adipose | 0.53069394 |
127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52778780 |
128 | MP0000371_diluted_coat_color | 0.51753495 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Systemic lupus erythematosus (HP:0002725) | 9.99612588 |
2 | Glomerulonephritis (HP:0000099) | 8.29873208 |
3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 7.21750017 |
4 | Abnormality of glycolipid metabolism (HP:0010969) | 7.21750017 |
5 | Abnormality of liposaccharide metabolism (HP:0010968) | 7.21750017 |
6 | Complement deficiency (HP:0004431) | 6.53077392 |
7 | Increased cerebral lipofuscin (HP:0011813) | 5.74891758 |
8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 5.15047250 |
9 | Arterial tortuosity (HP:0005116) | 5.10153114 |
10 | Cerebral aneurysm (HP:0004944) | 5.05775383 |
11 | Dysostosis multiplex (HP:0000943) | 5.04435593 |
12 | Abnormality of complement system (HP:0005339) | 5.00597452 |
13 | Recurrent abscess formation (HP:0002722) | 4.79142030 |
14 | Recurrent bacterial skin infections (HP:0005406) | 4.58791864 |
15 | Retinal atrophy (HP:0001105) | 4.53977957 |
16 | Vascular tortuosity (HP:0004948) | 4.46478620 |
17 | Nephritis (HP:0000123) | 4.24778735 |
18 | Hematochezia (HP:0002573) | 4.14977706 |
19 | Disinhibition (HP:0000734) | 3.95469187 |
20 | Eczematoid dermatitis (HP:0000976) | 3.94698843 |
21 | Vacuolated lymphocytes (HP:0001922) | 3.87061083 |
22 | Axonal loss (HP:0003447) | 3.82728448 |
23 | Mucopolysacchariduria (HP:0008155) | 3.81274561 |
24 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.81274561 |
25 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.61995215 |
26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.61995215 |
27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.61995215 |
28 | Aortic aneurysm (HP:0004942) | 3.56185583 |
29 | Orchitis (HP:0100796) | 3.52525442 |
30 | Urethral obstruction (HP:0000796) | 3.46618899 |
31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.32753706 |
32 | Agnosia (HP:0010524) | 3.30924039 |
33 | Retrobulbar optic neuritis (HP:0100654) | 3.25564662 |
34 | Optic neuritis (HP:0100653) | 3.25564662 |
35 | Disproportionate tall stature (HP:0001519) | 3.23652438 |
36 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.19379643 |
37 | Orthostatic hypotension (HP:0001278) | 3.14426711 |
38 | Stomatitis (HP:0010280) | 3.09916021 |
39 | Colitis (HP:0002583) | 3.09075299 |
40 | Neurofibrillary tangles (HP:0002185) | 2.95366944 |
41 | Progressive neurologic deterioration (HP:0002344) | 2.94745978 |
42 | Striae distensae (HP:0001065) | 2.93409381 |
43 | Upper motor neuron abnormality (HP:0002127) | 2.93261000 |
44 | Purpura (HP:0000979) | 2.86284004 |
45 | Hepatosplenomegaly (HP:0001433) | 2.85455726 |
46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.84419474 |
47 | Recurrent cutaneous fungal infections (HP:0011370) | 2.84419474 |
48 | Abnormality of macrophages (HP:0004311) | 2.81046655 |
49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.76877639 |
50 | Chronic diarrhea (HP:0002028) | 2.70390385 |
51 | Aortic dissection (HP:0002647) | 2.69641771 |
52 | Autoimmune thrombocytopenia (HP:0001973) | 2.64201866 |
53 | Meningitis (HP:0001287) | 2.62682555 |
54 | Recurrent skin infections (HP:0001581) | 2.59976594 |
55 | Pathologic fracture (HP:0002756) | 2.58339573 |
56 | Hemoptysis (HP:0002105) | 2.57996917 |
57 | Asymmetric septal hypertrophy (HP:0001670) | 2.52396846 |
58 | Pulmonary infiltrates (HP:0002113) | 2.48067194 |
59 | Amyloidosis (HP:0011034) | 2.45977977 |
60 | Increased serum ferritin (HP:0003281) | 2.44081185 |
61 | Loss of speech (HP:0002371) | 2.43679873 |
62 | Inflammation of the large intestine (HP:0002037) | 2.41940181 |
63 | Thoracic kyphosis (HP:0002942) | 2.41650899 |
64 | Cardiomegaly (HP:0001640) | 2.41546841 |
65 | Spondylolisthesis (HP:0003302) | 2.41280526 |
66 | Vasculitis (HP:0002633) | 2.35796930 |
67 | Nuclear cataract (HP:0100018) | 2.34795421 |
68 | Petechiae (HP:0000967) | 2.32638172 |
69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.30992697 |
70 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.30902271 |
71 | * Mutism (HP:0002300) | 2.27709868 |
72 | Arnold-Chiari malformation (HP:0002308) | 2.27345678 |
73 | Urticaria (HP:0001025) | 2.26869225 |
74 | Keratoconjunctivitis sicca (HP:0001097) | 2.25177467 |
75 | Mitral valve prolapse (HP:0001634) | 2.24155943 |
76 | Gastrointestinal inflammation (HP:0004386) | 2.23777673 |
77 | Epistaxis (HP:0000421) | 2.20819961 |
78 | Inappropriate behavior (HP:0000719) | 2.19134312 |
79 | Myocardial infarction (HP:0001658) | 2.18938776 |
80 | Abnormal platelet function (HP:0011869) | 2.18715347 |
81 | Impaired platelet aggregation (HP:0003540) | 2.18715347 |
82 | Malnutrition (HP:0004395) | 2.15364458 |
83 | Apathy (HP:0000741) | 2.14990286 |
84 | Pustule (HP:0200039) | 2.13989781 |
85 | Basal ganglia calcification (HP:0002135) | 2.13189772 |
86 | Increased IgE level (HP:0003212) | 2.12652779 |
87 | Abnormality of iron homeostasis (HP:0011031) | 2.09950732 |
88 | Encephalitis (HP:0002383) | 2.09901787 |
89 | Spontaneous hematomas (HP:0007420) | 2.09404389 |
90 | Myositis (HP:0100614) | 2.08891580 |
91 | Cerebral inclusion bodies (HP:0100314) | 2.08592475 |
92 | * Neuronal loss in central nervous system (HP:0002529) | 2.08447429 |
93 | Peripheral demyelination (HP:0011096) | 2.04740988 |
94 | Increased CSF protein (HP:0002922) | 2.03564570 |
95 | Diminished motivation (HP:0000745) | 2.02970983 |
96 | Keratoconjunctivitis (HP:0001096) | 2.02791591 |
97 | Polyneuropathy (HP:0001271) | 2.02464119 |
98 | Polygenic inheritance (HP:0010982) | 2.00572996 |
99 | Joint stiffness (HP:0001387) | 1.99976648 |
100 | J-shaped sella turcica (HP:0002680) | 1.98231486 |
101 | Gastrointestinal infarctions (HP:0005244) | 1.96983604 |
102 | Intestinal fistula (HP:0100819) | 1.95284756 |
103 | Pulmonary embolism (HP:0002204) | 1.95169451 |
104 | Leukocytosis (HP:0001974) | 1.94738089 |
105 | T lymphocytopenia (HP:0005403) | 1.94608451 |
106 | Conjunctival telangiectasia (HP:0000524) | 1.92784771 |
107 | Rectovaginal fistula (HP:0000143) | 1.91730242 |
108 | Rectal fistula (HP:0100590) | 1.91730242 |
109 | Urinary incontinence (HP:0000020) | 1.90592764 |
110 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.90396381 |
111 | Interstitial pulmonary disease (HP:0006530) | 1.90165539 |
112 | Abnormality of the lumbar spine (HP:0100712) | 1.87575585 |
113 | Gingival bleeding (HP:0000225) | 1.86987901 |
114 | Gingivitis (HP:0000230) | 1.86945961 |
115 | Bicuspid aortic valve (HP:0001647) | 1.86924640 |
116 | Prolonged bleeding time (HP:0003010) | 1.86734699 |
117 | Recurrent fungal infections (HP:0002841) | 1.85907012 |
118 | Global brain atrophy (HP:0002283) | 1.84186775 |
119 | Vaginal fistula (HP:0004320) | 1.83687662 |
120 | Cellulitis (HP:0100658) | 1.83043768 |
121 | Obstructive lung disease (HP:0006536) | 1.80564381 |
122 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80564381 |
123 | Progressive visual loss (HP:0000529) | 1.79429803 |
124 | Abnormality of the thoracic spine (HP:0100711) | 1.76617002 |
125 | Personality changes (HP:0000751) | 1.76133063 |
126 | Ovoid vertebral bodies (HP:0003300) | 1.75714913 |
127 | Bone pain (HP:0002653) | 1.74426585 |
128 | Exotropia (HP:0000577) | 1.73708128 |
129 | Recurrent viral infections (HP:0004429) | 1.73218105 |
130 | Clumsiness (HP:0002312) | 1.71620886 |
131 | Thickened calvaria (HP:0002684) | 1.69377312 |
132 | Mediastinal lymphadenopathy (HP:0100721) | 1.69311901 |
133 | Thick nail (HP:0001805) | 1.67424971 |
134 | Lower limb asymmetry (HP:0100559) | 1.66651913 |
135 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.62793235 |
136 | Osteolytic defects of the hand bones (HP:0009699) | 1.62793235 |
137 | Osteomyelitis (HP:0002754) | 1.61144317 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 8.26860658 |
2 | MAPK15 | 6.57309393 |
3 | GRK7 | 3.41032213 |
4 | TSSK6 | 3.10811319 |
5 | TYK2 | 2.77872844 |
6 | RIPK4 | 2.55752777 |
7 | PAK4 | 2.46938803 |
8 | CAMK1D | 2.34726462 |
9 | PRPF4B | 2.31169994 |
10 | BLK | 2.23383188 |
11 | TBK1 | 1.89258258 |
12 | CAMK1G | 1.86885422 |
13 | ERN1 | 1.86790882 |
14 | VRK1 | 1.81672513 |
15 | IRAK4 | 1.67964368 |
16 | MAP3K11 | 1.62552219 |
17 | NME2 | 1.58647429 |
18 | CLK1 | 1.55610302 |
19 | STK10 | 1.54062771 |
20 | CDC42BPA | 1.51992504 |
21 | JAK1 | 1.51103436 |
22 | IRAK3 | 1.50649515 |
23 | TAOK1 | 1.47296393 |
24 | DDR2 | 1.39538068 |
25 | PKN2 | 1.36968991 |
26 | TNK2 | 1.36709066 |
27 | MAP4K1 | 1.36394264 |
28 | MATK | 1.33068472 |
29 | EPHB1 | 1.32879194 |
30 | TAOK2 | 1.31027449 |
31 | FES | 1.30473045 |
32 | MAP2K3 | 1.27852409 |
33 | HCK | 1.27720858 |
34 | CAMKK2 | 1.24489374 |
35 | ZAP70 | 1.20544093 |
36 | PAK2 | 1.15646109 |
37 | CSK | 1.15597911 |
38 | MAPK12 | 1.15346913 |
39 | MAP3K1 | 1.14228489 |
40 | MOS | 1.13209830 |
41 | KIT | 1.11775152 |
42 | * CSF1R | 1.09957794 |
43 | JAK2 | 1.05219626 |
44 | EEF2K | 1.02496609 |
45 | CDK3 | 0.96589414 |
46 | PTK6 | 0.94689744 |
47 | BMPR2 | 0.93289197 |
48 | TRIB3 | 0.89701350 |
49 | PDK2 | 0.88314601 |
50 | CAMKK1 | 0.87638683 |
51 | LCK | 0.87494436 |
52 | MAP3K14 | 0.87144529 |
53 | SCYL2 | 0.86487614 |
54 | MAP3K9 | 0.84764736 |
55 | ITK | 0.83761430 |
56 | LYN | 0.81760460 |
57 | NEK9 | 0.81292382 |
58 | IKBKB | 0.80893198 |
59 | ACVR1B | 0.78897360 |
60 | TESK2 | 0.77795787 |
61 | MAP3K13 | 0.77518204 |
62 | MARK2 | 0.76896674 |
63 | MAP3K3 | 0.76590073 |
64 | KSR2 | 0.73165691 |
65 | CDK6 | 0.73105314 |
66 | PDK1 | 0.72272281 |
67 | SYK | 0.71140272 |
68 | SIK3 | 0.70619273 |
69 | ADRBK2 | 0.69683609 |
70 | MAPK7 | 0.68296853 |
71 | MAP3K10 | 0.66169809 |
72 | IRAK2 | 0.65902974 |
73 | FGR | 0.65540037 |
74 | ABL2 | 0.65389042 |
75 | SIK2 | 0.65323377 |
76 | CAMK4 | 0.63306316 |
77 | GSK3A | 0.61409193 |
78 | ICK | 0.60441074 |
79 | BTK | 0.60232284 |
80 | PIK3CG | 0.60202698 |
81 | PDPK1 | 0.57780204 |
82 | GRK5 | 0.56949472 |
83 | MAP3K5 | 0.55781982 |
84 | IRAK1 | 0.55683457 |
85 | TEC | 0.55325592 |
86 | PRKD2 | 0.54748548 |
87 | MAPKAPK2 | 0.54568001 |
88 | ARAF | 0.53870036 |
89 | RPS6KC1 | 0.52600598 |
90 | RPS6KL1 | 0.52600598 |
91 | MAPKAPK3 | 0.51411316 |
92 | MAPKAPK5 | 0.47444705 |
93 | DAPK2 | 0.47237064 |
94 | EGFR | 0.46929426 |
95 | GRK6 | 0.45255640 |
96 | IKBKE | 0.44926269 |
97 | TGFBR1 | 0.44325867 |
98 | PIM2 | 0.43044534 |
99 | MARK3 | 0.40931603 |
100 | RPS6KA6 | 0.40380285 |
101 | TAOK3 | 0.40280958 |
102 | TRPM7 | 0.39408817 |
103 | PRKD1 | 0.38637058 |
104 | PRKG2 | 0.37544855 |
105 | ABL1 | 0.37498543 |
106 | RIPK1 | 0.35167346 |
107 | MAPK4 | 0.34402719 |
108 | MAP2K6 | 0.34035250 |
109 | JAK3 | 0.32750868 |
110 | TYRO3 | 0.32743076 |
111 | STK11 | 0.32733926 |
112 | PIM1 | 0.31708756 |
113 | PTK2B | 0.31328027 |
114 | RPS6KA2 | 0.31275553 |
115 | MAP2K2 | 0.30693147 |
116 | RET | 0.30534340 |
117 | TXK | 0.29920129 |
118 | * IGF1R | 0.28848383 |
119 | RPS6KA4 | 0.28123681 |
120 | PRKAA2 | 0.24388483 |
121 | MELK | 0.22584956 |
122 | YES1 | 0.21232201 |
123 | PRKCD | 0.21001921 |
124 | FYN | 0.20795141 |
125 | MAP3K8 | 0.19403809 |
126 | CHUK | 0.19372573 |
127 | PDGFRB | 0.18948722 |
128 | SGK3 | 0.17870929 |
129 | SRC | 0.17405845 |
130 | TTN | 0.16867940 |
131 | PKN1 | 0.16659708 |
132 | MAP3K6 | 0.16447301 |
133 | FGFR3 | 0.15990049 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 4.97753050 |
2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 4.90122147 |
3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.50729824 |
4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 3.40884092 |
5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.36457651 |
6 | Lysosome_Homo sapiens_hsa04142 | 3.18817907 |
7 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.53576418 |
8 | Prion diseases_Homo sapiens_hsa05020 | 2.39504652 |
9 | Pertussis_Homo sapiens_hsa05133 | 2.39078245 |
10 | Allograft rejection_Homo sapiens_hsa05330 | 2.37956611 |
11 | Asthma_Homo sapiens_hsa05310 | 2.35102563 |
12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.33474006 |
13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22488227 |
14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 2.20951218 |
15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.17181089 |
16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.08996311 |
17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.01312806 |
18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.86660663 |
19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.84053931 |
20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.68768835 |
21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.62606175 |
22 | Tuberculosis_Homo sapiens_hsa05152 | 1.58834025 |
23 | Legionellosis_Homo sapiens_hsa05134 | 1.49340823 |
24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44751549 |
25 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.25316548 |
26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.24391265 |
27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16274593 |
28 | Phagosome_Homo sapiens_hsa04145 | 1.14788510 |
29 | Measles_Homo sapiens_hsa05162 | 1.14496804 |
30 | Influenza A_Homo sapiens_hsa05164 | 1.12192847 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.10267610 |
32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09975578 |
33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07298156 |
34 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.06866898 |
35 | Malaria_Homo sapiens_hsa05144 | 1.03224937 |
36 | Salmonella infection_Homo sapiens_hsa05132 | 1.00130206 |
37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95952742 |
38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.95233348 |
39 | Colorectal cancer_Homo sapiens_hsa05210 | 0.93068393 |
40 | Platelet activation_Homo sapiens_hsa04611 | 0.91721664 |
41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.91305800 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90558245 |
43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.89284927 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88673136 |
45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.88380488 |
46 | * Endocytosis_Homo sapiens_hsa04144 | 0.85500879 |
47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85130690 |
48 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.84274867 |
49 | ABC transporters_Homo sapiens_hsa02010 | 0.82587703 |
50 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81350878 |
51 | Hepatitis B_Homo sapiens_hsa05161 | 0.77702140 |
52 | Apoptosis_Homo sapiens_hsa04210 | 0.77509978 |
53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73889125 |
54 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.72989757 |
55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69945682 |
56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69279512 |
57 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66445510 |
58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65803573 |
59 | Shigellosis_Homo sapiens_hsa05131 | 0.65006080 |
60 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64741312 |
61 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63970950 |
62 | Mineral absorption_Homo sapiens_hsa04978 | 0.60621628 |
63 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.60541707 |
64 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.58086827 |
65 | Amoebiasis_Homo sapiens_hsa05146 | 0.58004136 |
66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55491649 |
67 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55438789 |
68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54714506 |
69 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.54283985 |
70 | Adherens junction_Homo sapiens_hsa04520 | 0.52821256 |
71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52780891 |
72 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.52037139 |
73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.51759790 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51736897 |
75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51526329 |
76 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.51491636 |
77 | Bladder cancer_Homo sapiens_hsa05219 | 0.50665713 |
78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50117420 |
79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49451910 |
80 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46155204 |
81 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.46055012 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44662866 |
83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43158313 |
84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42146495 |
85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39925066 |
86 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39820738 |
87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38590983 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37658800 |
89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.37519358 |
90 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37172562 |
91 | Glioma_Homo sapiens_hsa05214 | 0.36971994 |
92 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36532466 |
93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35542970 |
94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35326121 |
95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.34422846 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.33942088 |
97 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32945705 |
98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32852928 |
99 | Focal adhesion_Homo sapiens_hsa04510 | 0.32240518 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32082948 |
101 | Renin secretion_Homo sapiens_hsa04924 | 0.31401057 |
102 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31290568 |
103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.31107464 |
104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30563465 |
105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30486893 |
106 | Insulin resistance_Homo sapiens_hsa04931 | 0.30203375 |
107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.30023966 |
108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29810952 |
109 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29745489 |
110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.29647827 |
111 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29525680 |
112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.29273183 |
113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28366315 |
114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.24914787 |
115 | * Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.24781670 |
116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.24714058 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23760279 |
118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23723069 |
119 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.21779434 |
120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21088112 |
121 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20427450 |
122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20201118 |